Phytonet
Phytonet AG is a Switzerland-based B2B company that distributes more than 25 proprietary health ingredients globally and provides cGMP contract manufacturing through its CAPSIQ liquid-filled capsule platform, serving nutraceutical and pharmaceutical brand customers across Europe, Turkey, and Asia.
- Company typePrivate
- Founded2009
- HeadquartersSchindellegi, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Phytonet does
Phytonet AG is a Switzerland-based B2B health-ingredients and contract-manufacturing company organized into two synergistic divisions. The Health Ingredients Division sources, distributes, and holds exclusive global rights to a portfolio of more than 25 branded ingredients spanning probiotics (LiverDophilus, the Probi range, HiRaDophilus), bioavailability-enhanced nutraceuticals (Pterovita, CAVAQ10, CAVACURMIN, CannabiNext, NovoCurmin), botanicals (Ahiflower, Cognitaven, MaquiBright, Novusetin, Luzixine), and a Sucrosomial mineral suite, while the Pharmaceutical Division offers cGMP contract manufacturing certified to ISO 9001, HACCP, FDA, and FSSC 22000, anchored by the proprietary CAPSIQ Liquid-Filled Capsule Platform launched in November 2025.
The company's technical differentiation rests on patented delivery and formulation technologies, including the Sucrosomial mineral delivery system, the CAPSIQ two-piece hard-capsule platform for liquids and multi-phase actives, and cocrystal-engineered actives such as Pterovita (99% bioavailability, 9.9x higher blood levels) and WACKER's gamma-cyclodextrin CoQ10 and curcumin complexes. Scientific capabilities are supported by a team of pharmacists, physicians, and PhD researchers with two or more decades of experience, and by co-development partnerships with research institutions such as IBISS and IMGGE.
Phytonet's business model combines ingredient distribution (including exclusive distribution agreements for LUZIXINE with ASK Intercity and for Ahiflower with Natures Crops International) with contract manufacturing revenue and a small B2C shop at shop.phytonet.com. Pricing is not publicly disclosed; all enterprise engagement is conducted through dedicated inquiry forms and direct contact, with lead generation driven by participation in major trade shows (Vitafoods Europe, CPHI Milan, OEM Japan). The company is privately held, founder-led by Dr. Cem Aydogan, and operates without disclosed institutional investment.
Phytonet firmographics
Firmographics- Name
- Phytonet
- Legal name
- Phytonet AG
- Website
- https://phytonet.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Phytonet AG is a Switzerland-based B2B company that distributes more than 25 proprietary health ingredients globally and provides cGMP contract manufacturing through its CAPSIQ liquid-filled capsule platform, serving nutraceutical and pharmaceutical brand customers across Europe, Turkey, and Asia.
- Ownership category
- akta.pro rank
Phytonet industry classification
Industry- Product category
- Nutraceutical Ingredients & Contract Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Chemical and Allied Products Merchant Wholesalers (4246)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Food And Kindred Products (2000)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), Food-Grade Additives & Functional Ingredients Trading/Wholesale (AFAIAKAI), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO)
Keywords
Where Phytonet is headquartered
LocationHeadquarters
- HQ city
- Schindellegi
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Phytonet business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Health Ingredients Distribution: Phytonet sources and distributes innovative health ingredients to B2B clients globally. The Health Ingredients Division serves as a strategic collaborator in advancing healthcare, offering scientifically backed ingredients for nutraceutical and pharmaceutical formulations.
- Contract Manufacturing (Pharmaceutical Division): Phytonet's Pharmaceutical Division offers contract manufacturing services with state-of-the-art production facilities. The division specializes in producing probiotic-based finished products and advanced delivery systems including CAPSIQ liquid-filled capsules. Production follows cGMP standards with prestigious certifications (ISO 9001, cGMP, HACCP, FDA, FSSC 22000).
- Exclusive Distribution Partnerships: Phytonet serves as official exclusive distributor for proprietary ingredients including LUZIXINE (L-RD), demonstrating distribution partnerships for specialized health ingredients.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Phytonet product offering
Product offeringCore offering
Phytonet operates two synergistic divisions: a Health Ingredients Division that sources and distributes scientifically-backed nutraceutical and botanical ingredients (probiotics, bioavailability-enhanced compounds, Sucrosomial minerals) to B2B clients globally, and a Pharmaceutical Division offering cGMP-certified contract manufacturing of food supplements, probiotic finished products, and advanced capsule forms using the proprietary CAPSIQ liquid-filled capsule platform. The company also functions as an exclusive distributor for third-party-developed proprietary ingredients.
Product overview
Phytonet operates two synergistic divisions—Health Ingredients Division and Pharmaceutical Division—supported by a Center for Biotics Innovation. The Health Ingredients Division offers a comprehensive portfolio of scientifically-backed ingredients for B2B clients globally, including proprietary probiotic strains (LiverDophilus, Probi Digestis, Probi Defendum, Probi FerroSorb, Probi Osteo, HiRaDophilus), botanical extracts (Ahiflower, Cognitaven, Novusetin, MaquiBright, Eldosamb, Luzixine), bioavailability-enhanced ingredients (Cavacurmin, Cava Q10, Pterovita, CannabiNext, NovoCurmin, Micro Glucan), and the Sucrosomial mineral suite (Magnesium, Selenium, Chromium, Iodine, Zinc, Calcium). The Pharmaceutical Division provides contract manufacturing capabilities highlighted by the proprietary CAPSIQ Liquid-Filled Capsule Platform, an advanced delivery technology combining superior bioavailability of liquids with the precision of hard capsules, supporting clean-label, multi-phase, and targeted-release formulations across all health indications.
Differentiator
Problem solved
Functional benefit
Products and services
- CAPSIQ Liquid-Filled Capsule Platform Proprietary advanced two-piece hard capsule system enabling secure encapsulation of liquids, semi-liquids, suspensions, beads, pellets, or small capsules containing active ingredients. Combines superior bioavailability of liquid formulations with precision and stability of hard capsules, manufactured under cGMP conditions with ICH Q1 stability guidelines. Available for B2B contract manufacturing clients.
- Pharmaceutical Contract Manufacturing Services Contract manufacturing services through state-of-the-art cGMP-certified facilities producing probiotic-based finished products, tablets, capsules, sachets, and advanced delivery systems for B2B clients. Facilities hold ISO 9001, cGMP, HACCP, FDA, and FSSC 22000 certifications.
- Health Ingredients Distribution Strategic B2B distribution of scientifically-backed health ingredients covering probiotics, prebiotics, postbiotics, synbiotics, botanical extracts, bioavailability-enhanced compounds, and the Sucrosomial mineral suite for nutraceutical and pharmaceutical formulation clients globally.
- LiverDophilus Innovative patented probiotic solution based on Lactobacillus helveticus BGRA43 strain. Demonstrated significant potential in preclinical studies and a post-marketing clinical study for supporting patients with MASLD. Developed through collaboration with IBISS and IMGGE scientific institutions.
- Ahiflower Plant-based omega-3-6-9 fatty acid ingredient (Buglossoides arvensis seed oil) distributed in partnership with Natures Crops International. Authorized for use in dietary supplements and functional foods in Turkey. Provides complete omega wellness for immune and mental health applications.
- Cavacurmin Innovative curcumin complex developed by WACKER using gamma-cyclodextrin (CAVAMAX W8) complexation, achieving 40-fold increase in absorption and 18-fold higher bioavailability compared to standard turmeric extract.
- Cava Q10 Highly bioavailable coenzyme Q10 developed by WACKER through complexation with gamma-cyclodextrin (CAVAMAX W8), achieving 18-fold increase in bioavailability compared to conventional CoQ10 products.
- Cognitaven Green oat (Avena sativa) extract developed by Anklam Extract from immature aerial parts harvested before full flowering. Clinically proven to enhance cognitive function, working memory, and multitasking abilities. 2021 NutraIngredient finalist for Ingredient of the Year: Cognitive Function.
- Pterovita Highly bioavailable pterostilbene developed by CIRCE Scientific through cocrystal engineering combining pterostilbene and picolinic acid, achieving 99% bioavailability and 9.9x higher blood levels compared to regular pterostilbene. Supports cognitive function, antioxidant activity, DNA repair, and cellular health.
- Pterovita Cosmetics Topical pterostilbene cocrystal for skincare formulations. Supports antioxidant activity, skin radiation protection, and DNA repair for rejuvenating, anti-aging, and resilient skin applications.
- Serezin Clinically proven blend of Boswellia serrata (frankincense) and ginger extracts for restorative sleep and pain relief. Demonstrates 93% better quality of sleep over four weeks, reduces grogginess, and enhances mood.
- Nutricog Patented combination of Haritaki (Terminalia chebula) and Boswellia (Boswellia serrata) for comprehensive cognitive benefits including memory, focus, and problem-solving improvements. Clinically demonstrated significant benefits in 15 days.
- Novusetin Premium fisetin extract (minimum 95%) derived from Japanese fruit wax tree (Rhus succedanea). High ORAC value of 23,000 micromole TE/g. Supports cognitive health, longevity, and crosses the blood-brain barrier.
- CannabiNext Cannabinoid ingredient developed by İmuneks Farma using patented technology enhancing cannabinoid solubility and bioavailability, achieving over 500% higher blood concentrations than conventional products. Uses GRAS excipients approved by FDA, EFSA, KFDA, and Chinese FDA.
- Probi Digestis Probiotic ingredient containing Lactoplantibacillus plantarum 299v (LP299V), clinically proven to support gastrointestinal health. Backed by over 70 human clinical studies and documented in over 140 publications.
- Probi Defendum Probiotic immune concept combining Lactiplantibacillus plantarum HEAL9 and Lacticaseibacillus paracasei 8700:2 strains. Clinically studied in over 1,700 individuals for respiratory health support.
- Probi FerroSorb Combines Lactiplantibacillus plantarum 299v with iron for increased iron absorption. Clinically proven to increase iron absorption in the upper small intestine and support long-term iron status.
- Probi Osteo Probiotic bone health concept based on Lactiplantibacillus plantarum HEAL9, HEAL19, and Lacticaseibacillus paracasei 8700:2. Clinically documented to support bone health and maintain bone density.
- Reducose Proprietary water extract of mulberry leaf standardized to 4.5-5.5% 1-deoxynojirimycin (DNJ). Seven clinical studies demonstrate significant blood glucose reduction by inhibiting carbohydrate-digesting enzymes.
- NovoCurmin Curcumin ingredient developed by İmuneks Farma using patented matrix technology for enhanced curcumin solubility and bioavailability. Uses FDA GRAS and EFSA-approved food-grade excipients.
- Micro Glucan Highly purified, micronized 1-3/1-6 beta-glucan derived from Saccharomyces cerevisiae developed by İmuneks Farma. Over 80% of particles below 10 microns for enhanced bioavailability with clinically proven immune support.
- MaquiBright Patented premium Maqui berry extract standardized to minimum 25% delphinidins and 35% total anthocyanins. Clinically proven to increase tear production by 89% after 4 weeks for dry eye relief. Product of the Year at NutraIngredient Awards 2019.
- JustMaqui Maqui berry (Aristotelia chilensis) concentrated juice powder standardized to minimum 1.4% delphinidins and 2.0% total anthocyanins. Rich in antioxidants and supports bone health.
- Eldosamb Standardized elderberry extract with minimum 13% anthocyanins. Shows immunomodulatory properties by decreasing pro-inflammatory TNF-α and IFN-γ and increasing anti-inflammatory IL-10.
- Luzixine Concentrated source of Medicago Sativa (Alfalfa), the only one on the market. Recognized as Novel Food by European Commission. 100% plant-based, minimally processed with clean label and guaranteed French origin, sourced from L-RD. Distributed exclusively by Phytonet AG alongside ASK Intercity.
- HiRaDophilus Probiotic ingredient supporting digestive health and general wellbeing, strengthening gut health and protecting overall health.
- Bimuno Prebiotic ingredient positioned as the most scientifically supported prebiotic on the market for general wellness applications.
- Probi Sensia Psychobiotic-based probiotic for mental health support. Helps manage mental health conditions by influencing neurotransmitter production and reducing inflammation.
- NEM (Natural Eggshell Membrane) Natural eggshell membrane ingredient supporting bone and joint health, sport nutrition, and female health applications.
- Zynamite Plant-based energy and alertness ingredient supporting active nutrition and men's health applications.
- Delphinol Maqui berry extract supporting metabolic, skin, and bone health with antioxidant properties and general wellness benefits.
- Sucrosomial Minerals Suite Suite of mineral ingredients using proprietary Sucrosomial delivery technology, including Magnesium (SideMag/SideMag Marine), Selenium (UltraSel), Chromium (UltraChrome), Iodine (UltraIod), Zinc (UltraZin), and Calcium (UltraCal/UltraCal Sea). Technology enables high absorption without common adverse effects of conventional mineral supplements.
- Sucrosomial Iron (SiderAL) Sucrosomial Iron ingredient (SiderAL) leveraging patented Sucrosomial delivery technology for improved iron absorption and tolerability. Allows active iron to cross the gastric and intestinal environment without interacting with mucosa or other nutrients, absorbed at enteric level and passing directly into bloodstream. Awarded Readers' Ingredient of the Year at NutraIngredients Awards 2016.
Quantifiable outcome
- CAPSIQ technology achieves significantly higher bioavailability for omega-3s, CoQ10, and fat-soluble vitamins
- +6 more outcomes
Companies that use Phytonet
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
Phytonet technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Phytonet partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- ASK IntercitycorePhytonet AG alongside ASK Intercity unveiled LUZIXINE, the only concentrated source of Medicago Sativa on the market. Both companies serve as official exclusive distributors of Luzixine of L-RD, showcasing products at OEM Japan and beyond.
- Natures Crops InternationalcoreStrategic partnership for Ahiflower oil distribution. Natures Crops International is the exclusive worldwide manufacturer of Ahiflower oil. Partnership worked to achieve Turkish regulatory authorization for dietary supplements and functional foods.
- Institute for Biological Research 'Siniša Stanković' (IBISS)coreScientific institution collaborating with Phytonet on development of LiverDophilus probiotic solution based on Lactobacillus helveticus BGRA43 strain.
- Institute for Molecular Genetics and Genetic Engineering (IMGGE)coreScientific institution collaborating with Phytonet on development of LiverDophilus probiotic solution. Partnership represents successful example of scientific expertise and industrial development creating high-value health innovations.
- Luzerne Recherche et Développement (L-RD)coreL-RD has full control of LUZIXINE value chain and offers eco-designed product with guarantee of French origin. 100% plant-based and minimally processed, LUZIXINE offers clean label and guaranteed responsible sourcing. Phytonet and ASK Intercity serve as official exclusive distributors.
- WACKERcoreWACKER developed CAVAQ10 innovative product using gamma-cyclodextrin (CAVAMAX W8) for enhanced CoQ10 absorption. Also developed CAVACURMIN curcumin complex. Both products distributed through Phytonet's ingredient portfolio.
- CIRCE ScientificcoreDeveloped Pterovita highly bioavailable pterostilbene through cocrystal engineering combining pterostilbene and picolinic acid. Product serves dietary supplement, food & beverage, animal health, and pharmaceutical industries.
- Anklam ExtractcoreDeveloper of Cognitaven green oat extract for mental fitness and cognitive performance. Ingredient sourced from immature green oat plant harvested before full flowering.
- İmuneks FarmacoreDeveloped CannabiNext using internationally patented technology for enhanced cannabinoid solubility and bioavailability. Also developed NovoCurmin matrix technology and Micro Glucan 1-3/1-6 beta-glucan. All distributed through Phytonet.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Phytonet competitors and assessment
Company assessmentBroad incumbents
- dsm-firmenich: Dutch-Swiss nutrition and ingredients major offering vitamins, carotenoids, omega-3s, and premix solutions to pharma, food, and supplement customers worldwide. Comparable to Phytonet across vitamins/minerals, omega ingredients (Ahiflower), and supplement market channels, but at vastly larger scale and with backward integration into ingredient manufacturing.
- Catalent: Major global contract development and manufacturing organization (CDMO) with capabilities across softgel, hard capsule, and oral dose forms. Comparable to Phytonet's Pharmaceutical Division and CAPSIQ capsule manufacturing capability, but operating at substantially larger scale and across broader geographies.
- Glanbia Nutritionals: Global B2B ingredient solutions provider offering functional ingredient blends, proteins, and premixes across multiple health and nutrition categories. Comparable to Phytonet's Health Ingredients Division in B2B distribution and custom formulation services, but with far greater scale and broader portfolio.
- Kaneka Corporation: Large Japanese chemical company with a significant CoQ10 (ubiquinone) and supplement ingredient franchise, including branded versions like Kaneka QH. Comparable as a manufacturer/distributor of branded, clinically-backed nutraceutical ingredients such as Phytonet's Cava Q10 offering, but at meaningfully larger scale.
Direct peers
- BioGaia: Swedish probiotics specialist that licenses and distributes clinically documented Lactobacillus strains to brand customers worldwide. Closely comparable to Phytonet's Probi and HiRaDophilus probiotic offerings, with overlapping indication focus (gut, immune, oral health) and clinical evidence-led go-to-market.
- AB Biotics: Spanish probiotic company developing and commercializing proprietary probiotic strains for pharmaceutical, nutraceutical, and functional food applications. Comparable to Phytonet on probiotic strain development, clinical validation, and European B2B distribution.
- Lallemand Health Solutions: Canadian-headquartered probiotic manufacturer and B2B supplier with a broad strain portfolio across digestive, immune, and women's health. Comparable to Phytonet's probiotic and postbiotic offerings in clinical backing, strain diversity, and B2B contract manufacturing capabilities.
- Gnosis by Lesaffre: Business unit of Lesaffre focused on biotics (probiotics, nutritional yeasts, postbiotics) and human nutrition ingredients. Directly comparable to Phytonet's Center for Biotics Innovation, with similar positioning around clinically validated probiotic, prebiotic, and biotic ingredient systems for B2B customers.
- AIDP: US-based specialty ingredient distributor serving the dietary supplement and functional food industries with branded proprietary ingredients. Directly comparable to Phytonet's Health Ingredients Division distribution model, including exclusive partnerships with ingredient innovators and similar customer base of supplement brands.
- Probi AB: Swedish probiotics company that develops, manufactures, and distributes probiotic strains to B2B brand customers globally. Directly comparable to Phytonet's Probi-branded probiotic portfolio (Digestis, Defendum, FerroSorb, Osteo) and Center for Biotics Innovation positioning, with a similar science-led, B2B distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Phytonet social profiles
Digital presencePhytonet compliance and trust
Trust signalCompliance6 records
Phytonet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phytonet leadership team
Management profileNumber of profiles
Profiles8 records
Phytonet funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phytonet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phytonet
What does Phytonet do?
Phytonet operates two synergistic divisions: a Health Ingredients Division that sources and distributes scientifically-backed nutraceutical and botanical ingredients (probiotics, bioavailability-enhanced compounds, Sucrosomial minerals) to B2B clients globally, and a Pharmaceutical Division offering cGMP-certified contract manufacturing of food supplements, probiotic finished products, and advanced capsule forms using the proprietary CAPSIQ liquid-filled capsule platform. The company also functions as an exclusive distributor for third-party-developed proprietary ingredients.
Is Phytonet a public or private company?
Phytonet is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Phytonet founded?
Phytonet was founded in 2009. It employs 11 to 50 people.
Where is Phytonet based?
Phytonet is headquartered in Schindellegi, Switzerland, in the Europe region.
How does Phytonet make money?
Three revenue lines are on record. Health Ingredients Distribution is the primary driver. The others are contract Manufacturing (Pharmaceutical Division) and exclusive Distribution Partnerships.
Who are Phytonet's main competitors?
Broad incumbents on record are dsm-firmenich, Catalent, Glanbia Nutritionals and Kaneka Corporation. Direct peers are BioGaia, AB Biotics, Lallemand Health Solutions, Gnosis by Lesaffre, AIDP and Probi AB.
Does Phytonet have an API?
No public API is recorded for Phytonet.
What industry is Phytonet in?
Phytonet's product category is Nutraceutical Ingredients & Contract Manufacturing. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325411 and its SIC code is 2833.